Comparative Effects of Traditional Chinese Mind - Body Exercises on Cognitive Function in Middle-Aged and Older Adults: A Systematic Review and Network Meta-Analysis.

Exp Aging ResJul 13, 2026 (epub)
Clinical ResearchGeriatricsNeurology

Zhi Lv, Yu Geng, Hong Liu et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and network meta-analysis evaluated the effects of traditional Chinese mind-body exercises (TCMBEs) on cognitive function in adults aged 50 and older. Thirty-three randomized controlled trials with 2503 participants were analyzed. Baduanjin, Qigong, and Tai Chi significantly improved cognition compared to passive control, with Baduanjin showing the highest standardized mean difference of 0.37.

Key findings

  • Baduanjin improved cognition with a standardized mean difference of 0.37 compared to passive control.
  • Qigong showed a standardized mean difference of 0.33 in cognitive improvement.
  • Tai Chi had a standardized mean difference of 0.30 for cognitive function enhancement.
  • Higher weekly frequency and shorter session duration suggested greater cognitive benefits, though not statistically significant.

Why it matters

As cognitive decline is common in older adults, identifying effective interventions like TCMBEs can help clinicians recommend scalable exercise options to enhance cognitive health in this population.

Source

PubMed · PMID 42439187

Published in Exp Aging Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Geriatrics

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.